openPR Logo
Press release

Epilepsy Drugs Market Report 2023: Industry Overview, Size, Share, Trends & Forecast till 2028

07-06-2023 09:52 AM CET | Health & Medicine

Press release from: IMARC Group

Epilepsy Drugs Market

Epilepsy Drugs Market

Global Epilepsy Drugs Market Overview 2023-2028

The global epilepsy drugs market size reached US$ 2.16 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.52 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028. The rising prevalence of epilepsy, increasing incidences of brain cancer in the geriatric population, and extensive research and development (R&D) activities represent some of the key factors driving the market.

Epilepsy medications are prescribed to treat epilepsy, a disorder of the central nervous system (CNS) characterized by recurring and unpredictable seizures. This condition affects both mental and physical functions, leading to sudden sensations, loss of awareness, behavioral changes, and intense emotional distress. Epilepsy drugs come in different forms such as capsules, liquids, tablets, and syrups, and can be administered through intravenous (IV), oral, or intramuscular routes. They belong to three generations of anti-epileptic drugs (AEDs) and are effective in treating various types of seizures, including difficult-to-treat, mixed, partial onset, tonic-clonic, and acute repetitive seizures. These medications play a crucial role in preventing life-threatening side effects, ensuring safety, improving tolerability, and minimizing negative impacts on cognitive functions. As a result, epilepsy drugs are widely available in hospitals and pharmacies.

Request a free sample report:- https://www.imarcgroup.com/epilepsy-drugs-market/requestsample

Global Epilepsy Drugs Market Trends and Drivers:

The growing prevalence of epilepsy is primarily fueled by the increasing incidences of neurological disorders, birth-related injuries, infections, substance abuse, and road injuries. This trend is a key driving factor for the epilepsy drugs market. Additionally, there is a rising demand for these medications to control seizures, reduce their frequency, and mitigate the adverse effects associated with long-term treatments. This demand is crucial in helping patients regain their normal psychosocial and vocational activities, thereby contributing to market growth.

Furthermore, government bodies have implemented various policies to raise awareness about epilepsy, promote research, and provide support for more effective treatment options. These initiatives are further accelerating the global market. The aging population, which is more susceptible to developing critical conditions like brain cancer that can lead to seizures, also plays a significant role in driving market growth.

Global Epilepsy Drugs Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Abbott Laboratories, Alkem Laboratories Limited, Bausch Health Companies Inc., Eisai Co. Ltd., GSK plc, H. Lundbeck A/S, Jazz Pharmaceuticals plc, Novartis AG, Pfizer Inc., Sunovion Pharmaceuticals Inc. (Sumitomo Dainippon Pharma Co. Ltd.), UCB S.A., etc.

Browse complete report:- https://www.imarcgroup.com/epilepsy-drugs-market

The report has segmented the market on the basis of region, generation type, anti-epileptics drugs type and distribution channel.

Generation Type Insights

First Generation Drugs
Phenytoin
Carbamazepine
Oxcarbazepine
Valproate
Ethosuximide
Primidone
Phenobarbital
Second Generation Drugs
Levetiracetam
Lamotrigine
Topiramate
Pregabalin
Rufinamide
Zonisamide
Third Generation Drugs
Lacosamide
Perampanel
Eslicarbazepine Acetate
Ezogabine/Retigabine

The report has also provided a detailed breakup and analysis of the epilepsy drugs market based on the generation type. This includes first generation drugs (phenytoin, carbamazepine, oxcarbazepine, valproate, ethosuximide, primidone, and phenobarbital), second generation drugs (levetiracetam, lamotrigine, topiramate, pregabalin, rufinamide, and zonisamide), and third generation drugs (lacosamide, perampanel, eslicarbazepine acetate, and ezogabine/retigabine). According to the report, second generation drugs represented the largest segment.

Anti-Epileptics Drugs Type Insights

Narrow-Spectrum AEDs
Broad-Spectrum AEDs
A detailed breakup and analysis of the epilepsy drugs market based on the anti-epileptics drugs type has also been provided in the report. This includes narrow and broad-spectrum AEDs. According to the report, broad-spectrum AEDs accounted for the largest market share.

Distribution Channel Insights

Hospital Pharmacy
Pharmacy Stores
Others

A detailed breakup and analysis of the epilepsy drugs market based on the distribution channel has been provided in the report. This includes hospital pharmacy, pharmacy stores, and others. According to the report, hospital pharmacy accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for epilepsy drugs. Some of the factors driving the North America epilepsy drugs market growth include increasing burden of epilepsy, rising awareness campaigns, launching of new products, etc.

Speak to Analyst:- https://www.imarcgroup.com/request?type=report&id=6650&flag=C

If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

Market Performance (2017-2022)
Market Outlook (2023- 2028)
Porter's Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Related reports:-

Probiotics Market:- https://www.imarcgroup.com/probiotics-market

Plasma Fractionation Market:- https://www.imarcgroup.com/plasma-fractionation-market

Contact Us:

IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epilepsy Drugs Market Report 2023: Industry Overview, Size, Share, Trends & Forecast till 2028 here

News-ID: 3115845 • Views:

More Releases from IMARC Group

India Online Furniture Market Size 2025: Share, Trends, Growth Insights & Forecast Report 2033
India Online Furniture Market Size 2025: Share, Trends, Growth Insights & Foreca …
According to the latest report by IMARC Group, titled "India Online Furniture Market Report by Raw Material (Wood, Metal, Plastic, Jade, Glass), Product (Living Room Furniture, Bedroom Furniture, Office Furniture, Kitchen Furniture, and Others), Application (Residential, Commercial), and Region 2025-2033," the report presents a thorough review featuring the India Online Furniture Market growth, share, trends, and research of the industry. Market Size & Future Growth Potential: The India online furniture market size
LED Display Module Manufacturing Plant Project Report 2025
LED Display Module Manufacturing Plant Project Report 2025
An LED display module is a compact electronic unit made up of light-emitting diodes arranged on a circuit board to form visual displays. These modules are the building blocks of digital screens used in advertising boards, TVs, scoreboards, and indoor or outdoor signage. Known for their high brightness, energy efficiency, and durability, LED modules deliver superior image quality and visibility, making them essential in entertainment, retail, and public information systems. Setting
Renewable Graphite for Batteries Manufacturing Plant Project Report 2025
Renewable Graphite for Batteries Manufacturing Plant Project Report 2025
Setting up a renewable graphite for batteries manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Renewable Graphite for Batteries Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for
India Active Pharmaceutical Ingredients Market Size, Share, Industry Trends, Analysis & Growth Report 2025-2033
India Active Pharmaceutical Ingredients Market Size, Share, Industry Trends, Ana …
According to the latest report by IMARC Group, titled "India Active Pharmaceutical Ingredients Market Report by Drug Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Manufacturer Type (Captive API Manufacturers, Merchant API Manufacturers), Synthesis Type (Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), Therapeutic Application (Oncology, Cardiovascular and Respiratory, Diabetes, Central Nervous System Disorders, Neurological Disorders, and Others), and Region 2025-2033," the report presents a thorough review featuring the

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$